BCH (Standard)
Based on 1 Customer Validation
BCH (Standard) is the analytical standard of BCH. This product is intended for research and analytical applications. BCH (2-Amino-2-norbornanecarboxylic acid) is a selective and competitive inhibitor of large neutral amino acid transporter 1 (LAT1) significantly inhibit cellular uptake of amino acids and mTOR phosphorylation, which induces the suppression of cancer growth and apoptosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.84%
- No. CAS: 20448-79-7
- Fòrmula: C8H13NO2
- Peso molecular:155.20
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-108540
BCH
-
HY-13662
Lansoprazole
-
HY-17507
Pantoprazole
-
HY-B0572
Zinc Pyrithione
-
HY-B0656A
Rabeprazole sodium
-
HY-17022
Esomeprazole magnesium trihydrate
-
HY-B0656
Rabeprazole
-
HY-17507R
Pantoprazole (Standard)
-
HY-17023
Esomeprazole sodium
-
HY-B1446
Esomeprazole magnesium
-
HY-B0572R
Zinc Pyrithione (Standard)
-
HY-13662R
Lansoprazole (Standard)
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 20448-79-7
-
Appearance Solid
-
Peso molecular 155.20
-
Fòrmula C8H13NO2
-
Color White to off-white
-
SMILES
O=C(C1(N)C(C2)CCC2C1)O
-
Synonyms
2-Amino-2-norbornanecarboxylic acid (Standard); LAT1-IN-1 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Ohshima Y, et al. Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma. Cancer Sci. 2016 Oct;107(10):1499-1505. [Content Brief]
[2]. Singh N, et al. Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods. Int J Mol Sci. 2018 Dec 21;20(1). [Content Brief]
[3]. Wang Q, et al. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res. 2015 Mar 15;5(4):1281-94. eCollection 2015. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BCH (Standard) Related Classifications
HY-108540R Related Classifications
Powered by Bioz